Editor: Tamara L. Kalir

Ovarian Cancer – Challenges & Innovations

Printed Copy: US $57
ISBN: 978-981-14-2185-3 (Print)
ISBN: 978-981-14-2186-0 (Online)
Year of Publication: 2019
DOI: 10.2174/97898114218601190101

Introduction

This informative book provides a wealth of information on ovarian cancer. The book opens with a discussion of contemporary management of this disease with commentary on surgery and clinical trials: neoadjuvant, dose-dense, and heated intraperitoneal chemotherapy (HIPEC}, as well as immunotherapy, vaccine therapy, emerging therapies. This is followed by presentations on ovarian cancer pathology. A chapter is devoted to methods of drug discovery through a functional genomics approach, with gene expression microarray databases available in public data repositories such as Public Gene Expression Omnibus (GEO} and validation using immunohistochemistry or Ingenuity Pathway Analysis (IPA). Next, the book explores the psycho-social issues that may be encountered by an ovarian cancer patient, including commentary on pain, fertility, anxiety, depression, demoralization, caregiver burnout, and end-of-life. The final chapter represents a step out from mainstream medical practice and provides an exposition of the mind-body interaction and the powerful role of belief in the healing process, with discussions of the placebo effect, nocebo effect, and numerous research studies that demonstrate the tremendous influence of our beliefs on our bodies and well-being.

Key Features:

  • -Provides a holistic view of ovarian cancer.
  • -Covers both conventional medical research topics and key social issues encountered by patients, caregivers and medical professionals.
  • -Explains cancer pathology and related concepts with the help of illustrations and notes on future directions.
  • -Features commentary from experts in ovarian cancer treatment.
  • -Written in a reader-friendly style suitable for a wide range of readers

Ovarian Cancer – Challenges and Innovations is a comprehensive reference about ovarian cancer for medical students, residents, practitioners, healthcare support staff (nurses, physician assistants), medical researchers and scientists, as well as patients and interested laypersons seeking to improve their current knowledge of ovarian cancer.

Contributors

Editor(s):
Tamara L. Kalir




Contributor(s):
Jamal Rahaman
Division of Gynecologic Oncology
Icahn School of Medicine at Mount Sinai New York
New York
USA


Lorene M. Yoxtheimer
Tulane Medical Center
New Orleans, LA
USA


Jessica Beyda
St. Francis Hospital Roslyn.
New York
USA


Sedef Everest
Fellow in Pathology
The Mount Sinai Health
New York
USA


Stave Kohtz
Pathology Foundational Sciences
Central Michigan University College of Medicine
USA


Gonzalo Carrasco-Avino
Pathologist, Clinica las Condes, Pontificia Universidad Catolica de Chile, and Adjunct Assistant Professor of Pathology
The Icahn School of Medicine at Mount Sinai
New York
USA


Benjamin Greenbaum
Medicine and Pathology
The Icahn School of Medicine at Mount Sinai
New York
USA


Mireia Castillo-Martin
Molecular and Experimental Pathology Laboratory, Champalimaud Centre for the Unknown
Lisbon, Portugal; and Assistant Professor of Research, Department of Pathology, The Icahn School of Medicine at Mount Sinai
New York
USA


Adolof Firpo
The Icahn School of Medicine at Mount Sinai
New York
USA


Carlos Cordon-Cardo
The Icahn School of Medicine at Mount Sinai
New York
USA


Tamara Kalir
The Icahn School of Medicine at Mount Sinai
New York
USA


Jacob M. Appel
Psychiatry and Medical Education, Director of Ethics Education in Psychiatry
Icahn School of Medicine at Mount Sinai
New York
USA




RELATED BOOKS

.Frontiers in Clinical Drug Research - Anti-Cancer Agents.
.Head and Neck Cancer: Hallmarks of The Inflammation Ecosystem.
.Topics in Anti-Cancer Research.
.Frontiers in Clinical Drug Research - Anti-Cancer Agents.